SOURCE: Universal Detection Technology

January 23, 2008 07:00 ET

Universal Detection Technology Comments on Installation of More Bioterrorism Sensors on Streets of New York City

New York City Wants More Bioterrorism Sensors Installed on City Streets; DHS, Which Funds 90 Percent of the Program, Says It Is Willing to Install a Few of the Units

LOS ANGELES, CA--(Marketwire - January 23, 2008) - Universal Detection Technology (www.udetection.com) (OTCBB: UDTT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, commented on recent requests made by New York City to install more bioterrorism sensors on city streets.

In a recent move, New York City is asking for more bioterror sensors installed on city streets. City officials now battle with the federal government over the number of sensors. The officials want more of the units, which cost $100,000 each, but DHS officials, which funds 90 percent of the units' cost, say they prefer to wait for even newer technology, saying the government wants "accurate and affordable" bioterrorism protection for all cities. "It needs to be better," Russ Knocke, a spokesman for the DHS, said of the current units. Their technology was developed by Lawrence Livermore National Laboratory in Livermore, California. "The technology we currently have is very cost prohibitive for any wide-scale deployments," he said.

Universal Detection Technology's BSM-2000 is designed to be an autonomous real-time air monitor. The underlying technology is utilized in NASA's planetary protection program and the device is designed to act as a first line of defense against a potential bioterrorism event. UDTT believes that its BSM-2000 can overcome the cost-prohibitive problem that is associated with present real-time bioterrorism detection technologies. BSM-2000 is relatively inexpensive to maintain and is ideal for continuous monitoring of air for abnormal levels of bacterial spores, such as anthrax. Universal Detection Technology has commercialized the technology and has had some sales and is also looking to further enhance the systems capabilities to act as a front end trigger or alert to an attack of bioterrorism.

"NYC's request for more biosensors underscores the reality of the threat of bioterrorism. Our technology which was developed at NASA's Jet Propulsion Laboratory has been designed to work quickly as an early-warning system of bacterial spores," said Mr. Jacques Tizabi, UDTT's Chief Executive Officer.

UDTT is a supplier of counter terrorism services and technologies to private and government organizations. The Company owns the license to a patented technology developed at NASA's JPL and utilized in UDTT's BSM-2000 used for autonomous monitoring of the air for presence of airborne bacterial spores such as anthrax. UDTT also supplies detection kits for detection of up to 5 bioterrorism agents. Among the Company's other products are radiation detection systems, educational material & training DVDs, and antimicrobial chemicals.

For more information please visit www.udetection.com or

Email us at info@udetection.com.

About Universal Detection Technology

Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bio-terror 'smoke' detector that detects certain biohazard substances. For more information, please visit http://www.udetection.com.

Forward-Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact Information